Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Sensei Biotherapeutics
Biotech
Gilead abruptly parts ways with general counsel—Chutes & Ladders
Gilead abruptly parts ways with general counsel. Treg biotech turns new leadership leaf. Sensei says sayonara to C-suite.
Darren Incorvaia
,
Zoey Becker
Nov 21, 2025 8:30am
Sensei shrinks workforce by 65% as layoff warning comes to pass
Nov 14, 2025 10:33am
Sensei drops sole clinical-stage cancer drug, plans layoffs
Oct 30, 2025 9:52am
Sensei lays off 46% of staff, closes site to fund cancer trial
Nov 14, 2024 9:38am
Former AbbVie R&D chief tapped to run Tessera—Chutes & Ladders
Jun 3, 2022 9:30am
Sensei clinches $133M IPO to advance personalized cancer meds
Feb 4, 2021 8:10am
